Global Parenteral Nutrition Market Size, Share, Trends and Forecast 2022-2030

Description

Industry Insights
Due to the COVID-19 pandemic, the global Parenteral Nutrition market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Parenteral Nutrition market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Parenteral Nutrition landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In China, the key players of parenteral nutrition include Haisco Pharmaceutical Group, King York, Fresenius Kabi, Kelun Pharma, etc. Top four manufacturers hold a share over 38%.

This report focuses on Parenteral Nutrition volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Parenteral Nutrition market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Australia and South America, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Parenteral Nutrition market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Heat

Amino Acid

Vitamins

Segment by Application

Below 100ml

250ml

500ml

Above 1L

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Baxter

B. Braun

Fresenius Kabi

Kelun Pharma

Otsuka Pharmaceutical

JW Pharmaceutical

Pfizer

Teva Pharmaceutical

Haisco Pharmaceutical Group

King York

Cisen

Lummy

Grand Life Sciences

Medisan

BBCA Pharmaceutical

Biokin Pharmaceutical

Xi'an Libang Pharmaceutical

Lionco Pharmaceutical

China Meheco Kangli

TABLE OF CONTENT

1 Parenteral Nutrition Market Overview
1.1 Product Overview and Scope of Parenteral Nutrition

1.2 Parenteral Nutrition Segment by Type

1.2.1 Global Parenteral Nutrition Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Heat

1.2.3 Amino Acid

1.2.4 Vitamins

1.3 Parenteral Nutrition Segment by Application

1.3.1 Global Parenteral Nutrition Sales Comparison by Application: (2022-2028)

1.3.2 Below 100ml

1.3.3 250ml

1.3.4 500ml

1.3.5 Above 1L

1.4 Global Parenteral Nutrition Market Size Estimates and Forecasts

1.4.1 Global Parenteral Nutrition Revenue 2017-2028

1.4.2 Global Parenteral Nutrition Sales 2017-2028

1.4.3 Parenteral Nutrition Market Size by Region: 2017 Versus 2021 Versus 2028

2 Parenteral Nutrition Market Competition by Manufacturers

2.1 Global Parenteral Nutrition Sales Market Share by Manufacturers (2017-2022)

2.2 Global Parenteral Nutrition Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Parenteral Nutrition Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Parenteral Nutrition Manufacturing Sites, Area Served, Product Type

2.5 Parenteral Nutrition Market Competitive Situation and Trends

2.5.1 Parenteral Nutrition Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Parenteral Nutrition Players Market Share by Revenue

2.5.3 Global Parenteral Nutrition Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Parenteral Nutrition Retrospective Market Scenario by Region

3.1 Global Parenteral Nutrition Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Parenteral Nutrition Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Parenteral Nutrition Market Facts & Figures by Country

3.3.1 North America Parenteral Nutrition Sales by Country

3.3.2 North America Parenteral Nutrition Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Parenteral Nutrition Market Facts & Figures by Country

3.4.1 Europe Parenteral Nutrition Sales by Country

3.4.2 Europe Parenteral Nutrition Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Parenteral Nutrition Market Facts & Figures by Region

3.5.1 Asia Pacific Parenteral Nutrition Sales by Region

3.5.2 Asia Pacific Parenteral Nutrition Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Parenteral Nutrition Market Facts & Figures by Country

3.6.1 Latin America Parenteral Nutrition Sales by Country

3.6.2 Latin America Parenteral Nutrition Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Parenteral Nutrition Market Facts & Figures by Country

3.7.1 Middle East and Africa Parenteral Nutrition Sales by Country

3.7.2 Middle East and Africa Parenteral Nutrition Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Parenteral Nutrition Historic Market Analysis by Type

4.1 Global Parenteral Nutrition Sales Market Share by Type (2017-2022)

4.2 Global Parenteral Nutrition Revenue Market Share by Type (2017-2022)

4.3 Global Parenteral Nutrition Price by Type (2017-2022)

5 Global Parenteral Nutrition Historic Market Analysis by Application

5.1 Global Parenteral Nutrition Sales Market Share by Application (2017-2022)

5.2 Global Parenteral Nutrition Revenue Market Share by Application (2017-2022)

5.3 Global Parenteral Nutrition Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Corporation Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Baxter Parenteral Nutrition Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 B. Braun

6.2.1 B. Braun Corporation Information

6.2.2 B. Braun Description and Business Overview

6.2.3 B. Braun Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.2.4 B. Braun Parenteral Nutrition Product Portfolio

6.2.5 B. Braun Recent Developments/Updates

6.3 Fresenius Kabi

6.3.1 Fresenius Kabi Corporation Information

6.3.2 Fresenius Kabi Description and Business Overview

6.3.3 Fresenius Kabi Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Fresenius Kabi Parenteral Nutrition Product Portfolio

6.3.5 Fresenius Kabi Recent Developments/Updates

6.4 Kelun Pharma

6.4.1 Kelun Pharma Corporation Information

6.4.2 Kelun Pharma Description and Business Overview

6.4.3 Kelun Pharma Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Kelun Pharma Parenteral Nutrition Product Portfolio

6.4.5 Kelun Pharma Recent Developments/Updates

6.5 Otsuka Pharmaceutical

6.5.1 Otsuka Pharmaceutical Corporation Information

6.5.2 Otsuka Pharmaceutical Description and Business Overview

6.5.3 Otsuka Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Otsuka Pharmaceutical Parenteral Nutrition Product Portfolio

6.5.5 Otsuka Pharmaceutical Recent Developments/Updates

6.6 JW Pharmaceutical

6.6.1 JW Pharmaceutical Corporation Information

6.6.2 JW Pharmaceutical Description and Business Overview

6.6.3 JW Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.6.4 JW Pharmaceutical Parenteral Nutrition Product Portfolio

6.6.5 JW Pharmaceutical Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Pfizer Parenteral Nutrition Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Teva Pharmaceutical

6.8.1 Teva Pharmaceutical Corporation Information

6.8.2 Teva Pharmaceutical Description and Business Overview

6.8.3 Teva Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Teva Pharmaceutical Parenteral Nutrition Product Portfolio

6.8.5 Teva Pharmaceutical Recent Developments/Updates

6.9 Haisco Pharmaceutical Group

6.9.1 Haisco Pharmaceutical Group Corporation Information

6.9.2 Haisco Pharmaceutical Group Description and Business Overview

6.9.3 Haisco Pharmaceutical Group Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Haisco Pharmaceutical Group Parenteral Nutrition Product Portfolio

6.9.5 Haisco Pharmaceutical Group Recent Developments/Updates

6.10 King York

6.10.1 King York Corporation Information

6.10.2 King York Description and Business Overview

6.10.3 King York Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.10.4 King York Parenteral Nutrition Product Portfolio

6.10.5 King York Recent Developments/Updates

6.11 Cisen

6.11.1 Cisen Corporation Information

6.11.2 Cisen Parenteral Nutrition Description and Business Overview

6.11.3 Cisen Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Cisen Parenteral Nutrition Product Portfolio

6.11.5 Cisen Recent Developments/Updates

6.12 Lummy

6.12.1 Lummy Corporation Information

6.12.2 Lummy Parenteral Nutrition Description and Business Overview

6.12.3 Lummy Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Lummy Parenteral Nutrition Product Portfolio

6.12.5 Lummy Recent Developments/Updates

6.13 Grand Life Sciences

6.13.1 Grand Life Sciences Corporation Information

6.13.2 Grand Life Sciences Parenteral Nutrition Description and Business Overview

6.13.3 Grand Life Sciences Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Grand Life Sciences Parenteral Nutrition Product Portfolio

6.13.5 Grand Life Sciences Recent Developments/Updates

6.14 Medisan

6.14.1 Medisan Corporation Information

6.14.2 Medisan Parenteral Nutrition Description and Business Overview

6.14.3 Medisan Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Medisan Parenteral Nutrition Product Portfolio

6.14.5 Medisan Recent Developments/Updates

6.15 BBCA Pharmaceutical

6.15.1 BBCA Pharmaceutical Corporation Information

6.15.2 BBCA Pharmaceutical Parenteral Nutrition Description and Business Overview

6.15.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.15.4 BBCA Pharmaceutical Parenteral Nutrition Product Portfolio

6.15.5 BBCA Pharmaceutical Recent Developments/Updates

6.16 Biokin Pharmaceutical

6.16.1 Biokin Pharmaceutical Corporation Information

6.16.2 Biokin Pharmaceutical Parenteral Nutrition Description and Business Overview

6.16.3 Biokin Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Biokin Pharmaceutical Parenteral Nutrition Product Portfolio

6.16.5 Biokin Pharmaceutical Recent Developments/Updates

6.17 Xi'an Libang Pharmaceutical

6.17.1 Xi'an Libang Pharmaceutical Corporation Information

6.17.2 Xi'an Libang Pharmaceutical Parenteral Nutrition Description and Business Overview

6.17.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Product Portfolio

6.17.5 Xi'an Libang Pharmaceutical Recent Developments/Updates

6.18 Lionco Pharmaceutical

6.18.1 Lionco Pharmaceutical Corporation Information

6.18.2 Lionco Pharmaceutical Parenteral Nutrition Description and Business Overview

6.18.3 Lionco Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.18.4 Lionco Pharmaceutical Parenteral Nutrition Product Portfolio

6.18.5 Lionco Pharmaceutical Recent Developments/Updates

6.19 China Meheco Kangli

6.19.1 China Meheco Kangli Corporation Information

6.19.2 China Meheco Kangli Parenteral Nutrition Description and Business Overview

6.19.3 China Meheco Kangli Parenteral Nutrition Sales, Revenue and Gross Margin (2017-2022)

6.19.4 China Meheco Kangli Parenteral Nutrition Product Portfolio

6.19.5 China Meheco Kangli Recent Developments/Updates

7 Parenteral Nutrition Manufacturing Cost Analysis

7.1 Parenteral Nutrition Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Parenteral Nutrition

7.4 Parenteral Nutrition Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Parenteral Nutrition Distributors List

8.3 Parenteral Nutrition Customers

9 Parenteral Nutrition Market Dynamics

9.1 Parenteral Nutrition Industry Trends

9.2 Parenteral Nutrition Market Drivers

9.3 Parenteral Nutrition Market Challenges

9.4 Parenteral Nutrition Market Restraints

10 Global Market Forecast

10.1 Parenteral Nutrition Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Parenteral Nutrition by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Parenteral Nutrition by Type (2023-2028)

10.2 Parenteral Nutrition Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Parenteral Nutrition by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Parenteral Nutrition by Application (2023-2028)

10.3 Parenteral Nutrition Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Parenteral Nutrition by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Parenteral Nutrition by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample